The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthma-Reference-Cited by-同舟云学术

The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthma

Published:2023-07-20 Issue:2 Volume:62 Page:2300245
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:Eur Respir J

Author:

Nanzer Alexandra M.,Taylor Victoria^ORCID,Hearn Andrew P.,Kavanagh Joanne E.,Patrick Tanya,Green Linda,Thomson Louise,Lam Jodie,Fernandes Mariana,Roxas Cris,d'Ancona Grainne^ORCID,Kent Brian D.,Dhariwal Jaideep^ORCID,Jackson David J.

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference9 articles.

1. Obesity and asthma

2. Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma

3. Oral glucocorticoid-sparing effect of benralizumab in severe asthma;Nair;N Engl J Med,2017

4. Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma

5. Real-World Effectiveness and the Characteristics of a “Super-Responder” to Mepolizumab in Severe Eosinophilic Asthma

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of comorbidities on EQ-5D quality-of-life index in severe asthma;Journal of Allergy and Clinical Immunology: Global;2024-08

2. Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two‐Year Real‐World Data With Benralizumab;Clinical & Experimental Allergy;2024-07-31

3. Redefining asthma management: Remodeling, rehabilitation and remission;Canadian Journal of Respiratory, Critical Care, and Sleep Medicine;2024-07-03

4. Remission in asthma;Current Opinion in Pulmonary Medicine;2024-03-05

5. Obesity-related asthma: new insights leading to a different approach;Current Opinion in Pulmonary Medicine;2024-03-04